Kymera Therapeutics, Inc 10-K for FY2025
Kymera Therapeutics, Inc. (KYMR)
10-K
2026-02-26
For: 2025-12-31
View Original
Added on
April 10, 2026
About this 10-K
Kymera Therapeutics, Inc filed this 10-K on February 26, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $39.21M
- down 16.7% from $47.07M a year earlier
- Net loss
- $311.35M
- compared with a net loss of $223.86M a year earlier
- Diluted EPS
- -$3.69
- compared with -$2.98 a year earlier